Merck & Co., Inc. (NYSE:MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, ...

In just a couple of weeks' time, the White House locked down $1.9 trillion in cross-border agreements. That includes a ...

Resideo Technologies (NYSE:REZI) was trading higher as Oppenheimer upgraded the building products stock on a $1.59B agreement ...

Every investor aims to build a portfolio that grows steadily and delivers meaningful returns. Growth investing remains a time ...

Sarepta Therapeutics ( NASDAQ: SRPT) was upgraded to Neutral from Underweight at J.P. Morgan as it sees FDA's Elevidys hold removal recommendation in ambulatory patients as a clear win.

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...

Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major ...

Detailed price information for Integer Holdings Corp (ITGR-N) from The Globe and Mail including charting and trades.

Oppenheimer analyst Brian Nagel sees upside in Carvana stock to $450. CVNA is set to report its fiscal second-quarter ...

Analysts upgraded Carvana shares, arguing the company is a "digitally-driven disruptor" in the fractured used car market.

Carvana ( NYSE: CVNA) tracked higher on Friday after Oppenheimer boosted its rating on the auto retailer to Outperform after ...

In a recent market update, Boston Scientific’s financial trajectory got a new spin with Oppenheimer raising its price target ...